PAPER Gessel MM, Bernstein S, Kemper M, Teplow DB, Bowers MT
SEARCH RESULTS
331159 RESULTS
PAPER Lincoln KM, Richardson TE, Rutter L, Gonzalez P, Simpkins JW, Green KN
An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation.
ACS Chem Neurosci. 2012 Nov 21;3(11):919-27. PubMed: 23173072PAPER Soper JH, Sugiyama S, Herbst-Robinson K, James MJ, Wang X, Trojanowski JQ, Smith AB, Lee VM, Ballatore C, Brunden KR
Brain-Penetrant Tetrahydronaphthalene Thromboxane A2-Prostanoid (TP) Receptor Antagonists as Prototype Therapeutics for Alzheimer's Disease.
ACS Chem Neurosci. 2012 Nov 21;3(11):928-40. PubMed: 23173073PAPER Naldi M, Fiori J, Pistolozzi M, Drake AF, Bertucci C, Wu R, Mlynarczyk K, Filipek S, De Simone A, Andrisano V
Amyloid β-Peptide 25-35 Self-Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment.
ACS Chem Neurosci. 2012 Nov 21;3(11):952-62. PubMed: 23173074PAPER Velasco PT, Heffern MC, Sebollela A, Popova IA, Lacor PN, Lee KB, Sun X, Tiano BN, Viola KL, Eckermann AL, Meade TJ, Klein WL
Synapse-Binding Subpopulations of Aβ Oligomers Sensitive to Peptide Assembly Blockers and scFv Antibodies.
ACS Chem Neurosci. 2012 Nov 21;3(11):972-81. PubMed: 23173076PAPER Schölzel-Dorenbos CJ, Arons AM, Wammes JJ, Rikkert M, Krabbe PF
Validation study of the prototype of a disease-specific index measure for health-related quality of life in dementia.
Health Qual Life Outcomes. 2012;10:118. PubMed: 23009579PAPER Sussman F, Villaverde MC, Domínguez JL, Danielson UH
On the Active Site Protonation State in Aspartic Proteases: Implications for Drug Design.
Curr Pharm Des. 2012 Nov 20; PubMed: 23170891PAPER
Clinical and biomarker changes in Alzheimer's disease.
PLoS One. 2012;7(11):e49876. PubMed: 23171103PAPER Laske C
Clinical and biomarker changes in Alzheimer's disease.
N Engl J Med. 2012 Nov 22;367(21):2050; author reply 2051-2. PubMed: 23171104PAPER Florez JC
Clinical and biomarker changes in Alzheimer's disease.
N Engl J Med. 2012 Nov 22;367(21):2051; author reply 2051-2. PubMed: 23171106PAPER Pimplikar SW
Clinical and biomarker changes in Alzheimer's disease.
N Engl J Med. 2012 Nov 22;367(21):2050-1; author reply 2051-2. PubMed: 23171105PAPER Helwig M, Hoshino A, Berridge C, Lee SN, Lorenzen N, Otzen DE, Eriksen JL, Lindberg I
The Neuroendocrine Protein 7B2 Suppresses the Aggregation of Neurodegenerative Disease-related Proteins.
J Biol Chem. 2013 Jan 11;288(2):1114-24. PubMed: 23172224PAPER Li F, Jia XF, Jia J
The Informant Questionnaire on Cognitive Decline in the Elderly individuals in screening mild cognitive impairment with or without functional impairment.
J Geriatr Psychiatry Neurol. 2012 Dec;25(4):227-32. PubMed: 23172761PAPER Boban M, Malojcić B, Mimica N, Vuković S, Zrilić I
The frontal assessment battery in the differential diagnosis of dementia.
J Geriatr Psychiatry Neurol. 2012 Dec;25(4):201-7. PubMed: 23172762Erica Andreozzi
King's CollegeLondon
Current Filters
No filters selected